why choose us

First received: October 09, 2022

Clinical Trial: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Nonalcoholic Steatohepatitis (NASH)

Study Type: INTERVENTIONAL


Official Title: A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of CS0159 in the Treatment of Patients With Nonalcoholic

Brief Summary: A randomized, double-blind study to assess the safety, tolerability, PK and efficacy of CS0159 in subjects with Non-Alcoholic Steatohepatitis (NASH)

Read more